F
Firebrick Pharma Ltd
ASX:FRE
Firebrick Pharma Ltd
ASX:FRE
Price:
0.068
AUD
6.25%
Market Closed
Market Cap:
AU$17.1m
Income Statement
Earnings Waterfall
Firebrick Pharma Ltd
Firebrick Pharma Ltd
Income Statement
Firebrick Pharma Ltd
Firebrick Pharma Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-61%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+1 357%
|
0
+39%
|
|
| Gross Profit | ||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
-11%
|
|
| Operating Income | ||||||||
| Operating Expenses |
(5)
|
(7)
|
(7)
|
(6)
|
(4)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
(2)
|
(4)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(5)
N/A
|
(7)
-34%
|
(7)
-5%
|
(6)
+6%
|
(4)
+39%
|
(3)
+32%
|
(3)
-8%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
1
|
0
|
2
|
3
|
1
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(5)
-42%
|
(7)
-26%
|
(5)
+33%
|
(1)
+74%
|
(2)
-47%
|
(3)
-53%
|
|
| Net Income | ||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(5)
|
(7)
|
(5)
|
(1)
|
(2)
|
(3)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-42%
|
(7)
-26%
|
(5)
+33%
|
(1)
+74%
|
(2)
-47%
|
(3)
-53%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.03
N/A
|
-0.04
-33%
|
-0.03
+25%
|
-0.01
+67%
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
